Header cover image
  • Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies

Results

476

0 new

Companies with a Value score of at least 3, ordered by Value score

476 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
ATRA
Atara Biotherapeutics		US$8.59-14.6%-55.4%US$49.5mUS$13.25PS0.5xE43.6%n/a
TNXP
Tonix Pharmaceuticals Holding		US$11.95-3.6%-99.0%US$22.3mUS$583.33PS2xE7.7%n/a
BNGO
Bionano Genomics		US$5.76-1.4%-92.3%US$9.8mUS$60.00PS0.3xE62.2%n/a
BIOR.Q
Biora Therapeutics		US$0.12-23.0%-98.5%US$541.8kUS$34.00PS0.6xE-21.5%n/a
BIAF
bioAffinity Technologies		US$0.803.1%-47.1%US$12.5mUS$6.00PS1.3xE-10.4%n/a
MNKD
MannKind		US$5.42-3.7%48.5%US$1.5bUS$10.00PE69.3xE33.1%n/a
SCPH
scPharmaceuticals		US$3.6813.2%-35.9%US$184.1mUS$17.50PS6.1xE58.9%n/a
RARE
Ultragenyx Pharmaceutical		US$42.49-6.3%-13.1%US$3.9bUS$90.74PS7xE63.3%n/a
CTNM
Contineum Therapeutics		US$7.73-8.1%n/aUS$199.3mUS$29.25PB0.9xS48.0%n/a
SRRK
Scholar Rock Holding		US$37.07-7.2%133.6%US$3.5bUS$48.75PB43.8xE55.9%n/a
DYN
Dyne Therapeutics		US$13.91-9.5%-39.3%US$1.4bUS$49.50PB2xE19.8%n/a
CLLS
Cellectis		US$1.551.3%-46.4%US$154.1mn/aPS4.5xE30.1%n/a
RNA
Avidity Biosciences		US$32.31-7.5%127.9%US$3.9bUS$67.91PS381xE34.3%n/a
IMUX
Immunic		US$1.004.1%-20.6%US$90.1mUS$13.17PB2.2xE60.3%n/a
GERN
Geron		US$2.56-12.6%27.4%US$1.5bUS$7.88PS52.5xE58.2%n/a
ESAL.F
Eisai		US$29.750%-32.2%US$1.2tUS$37.83PE20.9xE5.2%3.7%
MIST
Milestone Pharmaceuticals		US$2.275.6%48.4%US$150.4mUS$10.25PB6.3xE55.9%n/a
SWOB.Y
Swedish Orphan Biovitrum		US$13.45-8.8%10.1%US$106.3bUS$16.07PE27.4xE16.8%n/a
HKMP.Y
Hikma Pharmaceuticals		US$58.782.3%17.8%US$5.1bUS$62.61PE22.4xE11.0%2.7%
REZN.F
Street Capital		US$0.0006-73.9%n/aUS$1.4mn/aPS3.2xn/an/a
Page 20 of 20